Literature DB >> 17599344

Generation and characterization of stromal cell independent IL-7 dependent B cell lines.

Steven A Corfe1, Alice P Gray, Christopher J Paige.   

Abstract

In-vitro B cell cultures have played a significant role in the study of B cell development. Their utility in developmental and biochemical studies, however, has been limited by the challenges associated with obtaining and maintaining adequate cell numbers of pure and/or rare populations. Although B cell lines allow for circumvention of some of these issues, they have traditionally been generated via viral infection or genetic transformation and are thus less representative of in-vivo cells. In order to avoid such alterations in cell state, we have designed a procedure for the creation of B cell lines directly from murine bone marrow. In this study, we describe the generation and characterization of these IL-7 dependent cell lines. Our lines, established from both wild type and mutant mice, do not require stromal cell support for generation or maintenance. In addition, clones survive repeated freeze/thaw cycles and, in the presence of IL-7, can be kept in culture indefinitely. Phenotypically, our lines resemble pro/pre-B cells and exhibit IL-7 and preBCR signaling profiles that mimic ex-vivo B cells. These lines promise to be useful in the study of the signaling pathways that regulate B cell development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17599344     DOI: 10.1016/j.jim.2007.05.010

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  7 in total

1.  A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κ E3' enhancer.

Authors:  Suchita Hodawadekar; Kyoungsook Park; Michael A Farrar; Michael L Atchison
Journal:  J Immunol       Date:  2012-01-25       Impact factor: 5.422

2.  Focal adhesion kinase regulates the localization and retention of pro-B cells in bone marrow microenvironments.

Authors:  Shin-Young Park; Peter Wolfram; Kimberly Canty; Brendan Harley; César Nombela-Arrieta; Gregory Pivarnik; John Manis; Hilary E Beggs; Leslie E Silberstein
Journal:  J Immunol       Date:  2012-12-21       Impact factor: 5.422

3.  EBV LMP2A provides a surrogate pre-B cell receptor signal through constitutive activation of the ERK/MAPK pathway.

Authors:  Leah J Anderson; Richard Longnecker
Journal:  J Gen Virol       Date:  2008-07       Impact factor: 3.891

4.  An essential role for the Zn2+ transporter ZIP7 in B cell development.

Authors:  Consuelo Anzilotti; David J Swan; Bertrand Boisson; Mukta Deobagkar-Lele; Catarina Oliveira; Pauline Chabosseau; Karin R Engelhardt; Xijin Xu; Rui Chen; Luis Alvarez; Rolando Berlinguer-Palmini; Katherine R Bull; Eleanor Cawthorne; Adam P Cribbs; Tanya L Crockford; Tarana Singh Dang; Amy Fearn; Emma J Fenech; Sarah J de Jong; B Christoffer Lagerholm; Cindy S Ma; David Sims; Bert van den Berg; Yaobo Xu; Andrew J Cant; Gary Kleiner; T Ronan Leahy; M Teresa de la Morena; Jennifer M Puck; Ralph S Shapiro; Mirjam van der Burg; J Ross Chapman; John C Christianson; Benjamin Davies; John A McGrath; Stefan Przyborski; Mauro Santibanez Koref; Stuart G Tangye; Andreas Werner; Guy A Rutter; Sergi Padilla-Parra; Jean-Laurent Casanova; Richard J Cornall; Mary Ellen Conley; Sophie Hambleton
Journal:  Nat Immunol       Date:  2019-02-04       Impact factor: 25.606

5.  Daedalus: a robust, turnkey platform for rapid production of decigram quantities of active recombinant proteins in human cell lines using novel lentiviral vectors.

Authors:  Ashok D Bandaranayake; Colin Correnti; Byoung Y Ryu; Michelle Brault; Roland K Strong; David J Rawlings
Journal:  Nucleic Acids Res       Date:  2011-09-12       Impact factor: 16.971

6.  Towards the generation of B-cell receptor retrogenic mice.

Authors:  Jenny Freitag; Sylvia Heink; Edith Roth; Jürgen Wittmann; Hans-Martin Jäck; Thomas Kamradt
Journal:  PLoS One       Date:  2014-10-08       Impact factor: 3.240

7.  SHP2 is required for BCR-ABL1-induced hematologic neoplasia.

Authors:  S Gu; A Sayad; G Chan; W Yang; Z Lu; C Virtanen; R A Van Etten; B G Neel
Journal:  Leukemia       Date:  2017-08-14       Impact factor: 11.528

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.